HPLC Separation of Fenofibric Acid and Fenofibrate on Primesep 100 Column

HPLC Method for Fenofibric acid, Fenofibrate on Primesep 100 by SIELC Technologies

High Performance Liquid Chromatography (HPLC) Method for Analysis of Fenofibric acid, Fenofibrate.

Fenofibric acid is used to treat high levels of cholesterol and triglyceride in blood, which can help prevent pancreatitis. It works through activating peroxisome proliferator-activated receptor alpha. This leads to increased activity lipoprotein lipase and decreased production of proprotein.

Fenofibrate is used to treat high levels of cholesterol and triglyceride in blood, which can help prevent pancreatitis. It works when it is converted into Fenofibric acid, listed above.

Fenofibric acid, Fenofibrate can be retained and analyzed using the Primesep 100 stationary phase column. The analysis utilizes an isocratic method with a simple mobile phase consisting of water and acetonitrile (MeCN) with a formic acid buffer. Detection is performed using UV.

Condition

Column Solid-Core Primesep 100, 2.1 x 100 mm, 2.7 µm, 90 A, dual ended
Mobile Phase MeCN – 60%
Buffer Formic Acid  – 0.05%
Flow Rate 0.2 ml/min
Detection UV, 286 nm

Description

Class of Compounds
Drug,  Acid, Hydrophilic, Ionizable, Supplements
Analyzing Compounds Fenofibric acid, Fenofibrate

Application Column

Solid-Core Primesep 100

Column Diameter: 2.1 mm
Column Length: 100 mm
Particle Size: 2.7 µm
Pore Size: 90 A
Attribute: none
Column options: dual ended

Add to cart
Application Analytes:
Fenofibrate
Fenofibric acid

Application Detection:
UV Detection
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.